30 Under 30 2020: Meet The Sports World’s Brightest Young Stars [Forbes]
Denali Therapeutics Inc. (DNLI)
Last denali therapeutics inc. earnings: 8/6 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.denalitherapeutics.com
Company Research
Source: Forbes
30 Under 30 2020: Meet The Sports World’s Brightest Young Stars Edited by Chris Smith and Dan Kleinman Sports are famously a young person’s game, which means the competition is fierce for the Forbes Perhaps none are more impressive than Seattle Seahawks linebacker Bobby Wagner. The 29-year-old NFL star has been to five Pro Bowls and earned four first-team All-Pro nods and helped lead the Seahawks to their first-ever Super Bowl victory in 2013. And he’s been just as prolific off the field. Gallery: 2020 30 : Sports 31 images View gallery Wagner made a five-figure investment into Denali Therapeutics in 2014, and he recently joined the likes of Diddy and Shonda Rhimes in Andreessen Horowitz’s $500,000 minimum investment Cultural Fund (the portfolio features companies like Hipcamp and Lime scooters). “We should take the time to learn and understand how to make the money work for us,” says Wagner, “versus working for the money.” Last summer, Wagner negotiated his own three-year, $54 milli
Show less
Read more
Impact Snapshot
Event Time:
DNLI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNLI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNLI alerts
High impacting Denali Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
DNLI
News
- Denali Therapeutics Inc. (NASDAQ: DNLI) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $37.00 price target on the stock.MarketBeat
- Why Is Denali Therapeutics (DNLI) Down 21.2% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Denali Starts Dosing in Phase II Parkinson's Disease Study [Yahoo! Finance]Yahoo! Finance
- Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson's Disease [Yahoo! Finance]Yahoo! Finance
- Denali Therapeutics Announces First Participant Dosed in Phase 2a Study of LRRK2 Inhibitor, BIIB122, in LRRK2-Associated Parkinson’s DiseaseGlobeNewswire
DNLI
Earnings
- 11/6/24 - Miss
DNLI
Sec Filings
- 11/27/24 - Form 4
- 11/26/24 - Form 4
- 11/18/24 - Form 8-K
- DNLI's page on the SEC website